CMSC: Natalizumab for MS During the Covid-19 Pandemic
Overall outcomes good after Covid infection, vaccine for most patients At the recent Consortium of...
CMSC 2021
CMSC: Real-World Study Confirms Dimethyl Fumarate Safety
GI disorders most common reason for Tx discontinuation Safety is always a concern for any...
CMSC: Most MS Providers Think Diroximel Fumarate Has Better GI Profile
Prescribers cite tolerability when switching from other DMTs For those who doubt the effectiveness...
CMSC 2021: A Focus on Multiple Sclerosis eBook
Focus on Multiple Sclerosis CMSC eBook
COVID-19 Pandemic Profoundly Changes Delivery of MS Care
The COVID-19 pandemic resulted in unforeseen changes in healthcare delivery for patients with MS, and the pandemic’s swift progression led to a knowledge gap about how the virus has impacted practice patterns for MS clinicians,...
COVID-19 Pandemic Negatively Impacts Social Well-Being of Patients With MS
Currently, no research has reviewed the social consequences of the COVID-19 pandemic on patients with MS, who may experience greater social strain and more serious health consequences because of isolation measures, according to...
CMSC: Aggressive Versus Escalating MS Treatment Strategies
Ongoing trials may shed light on which is better In people newly diagnosed with relapsing multiple...
CMSC Annual Meeting Session Brochure (2021)
2021programbook_final_lowres Download CMSC 2021 Session Brochure (PDF)
CMSC 2021 Program and Accepted Abstracts
2021programbook_final_lowres View CMSC 2021 Accepted Abstracts A Look at D Platform Abstracts: DMT01 Design of the Phase II, Double-Blind, Placebo-Controlled Dose-Expansion Portion of a Two-Part, Phase I/II,...
CMSC 2021 Annual Meeting Around the Corner
This year’s Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, the leading research and educational conference for MS healthcare professionals in North America, kicks off tomorrow, October 25 through October...
Telerehabilitation During Isolation Improves QOL in Patients With MS
Investigators sought to assess the impact of telerehabilitation in patients with MS during the isolation period of the COVID-19 pandemic. They conducted a retrospective analysis using medical records from adults with MS and...
